cao亚洲欧美国产_成人毛片视频电影_男女爱视频免费高清在线观看_是一家值得信赖的金融服务机构_国产国产视频精品欧美视频_亚洲中文字幕久久私人影院_尤物在线精品视频_黄污网站在线观看_欧美日韩亚洲免费观看_国产剧情在线播放

One of Joint Biosciences' lead products, OVV-01, is a recombinant vesicular stomatitis virus (VSV) engineered to express the NY-ESO-1 tumor-associated antigen. It is currently being investigated  in a Phase 2 clinical trial for the treatment of patients with soft tissue sarcoma. We are actively conducting clinical trials to obtain regulatory approval and in order to expedite broader patient access to OVV-01. At this stage of development, we believe participation in our clinical trials is the most appropriate pathway to access OVV-01. Information about our clinical trials, including eligibility criteria and trial locations, will be available at ClinicalTrials.gov.

Joint Biosciences acknowledges the interest of patients in accessing OVV-01 outside of clinical trials, particularly for life-threatening conditions prior to regulatory approval. However, we currently do not offer Expanded Access Programs (EAPs) for OVV-01 but will continue to evaluate this policy based on emerging data from ongoing and future clinical trials.

2025/2/25